Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Other Operating Expenses: 2011-2024

Historic Other Operating Expenses for Veracyte (VCYT) over the last 14 years, with Dec 2024 value amounting to $102.1 million.

  • Veracyte's Other Operating Expenses rose 5.91% to $25.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.0 million, marking a year-over-year decrease of 5.00%. This contributed to the annual value of $102.1 million for FY2024, which is 40.62% down from last year.
  • As of FY2024, Veracyte's Other Operating Expenses stood at $102.1 million, which was down 40.62% from $171.9 million recorded in FY2023.
  • Over the past 5 years, Veracyte's Other Operating Expenses peaked at $171.9 million during FY2023, and registered a low of $98.9 million during FY2020.
  • Moreover, its 3-year median value for Other Operating Expenses was $103.0 million (2022), whereas its average is $125.7 million.
  • In the last 5 years, Veracyte's Other Operating Expenses skyrocketed by 72.05% in 2021 and then slumped by 40.62% in 2024.
  • Yearly analysis of 5 years shows Veracyte's Other Operating Expenses stood at $98.9 million in 2020, then soared by 72.05% to $170.2 million in 2021, then tumbled by 39.51% to $103.0 million in 2022, then soared by 67.00% to $171.9 million in 2023, then slumped by 40.62% to $102.1 million in 2024.